Become a Member
Dark Mode
Become a Member
Elections 2024
Elections Fact-Check
Compare Manifestos
Electoral Bonds
Manipur: A Year On
Uncovering Hate
'Trapped' in Russia
Members Only
Neon
More
FIT
Webqoof
My Report
Brand Studio
Indian Diaspora
Entertainment
Opinion
World
Videos
Podcasts
Sports
Law
More
Gender
Climate Change
FAQs
Explainers
Graphic Novels
Education
Quint Lab
Business
Good News
Members' Opinion
Photos
Dark Mode
Become a Member
Home
Elections
Jobs
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
Covaxin Efficacy
Covaxin Has 77.8% Efficacy Against COVID: Phase 3 Data in the Lancet
Covaxin Effective Against Delta Plus Covid Variant: ICMR Study
ADVERTISEMENT
REMOVE AD
Decoding Covaxin's Final Phase 3 Trial Data With Dr Shahid Jameel
Covaxin COVID Vaccine 77.8% Effective; 10 Things to Know About the Phase 3 Data
'Covaxin Has 77.8% Efficacy in Phase 3': What Do We Know So Far?
Covaxin Has 77.8% Efficacy Against COVID: Phase 3 Data in the Lancet
Covaxin Effective Against Delta Plus Covid Variant: ICMR Study
Decoding Covaxin's Final Phase 3 Trial Data With Dr Shahid Jameel
Covaxin COVID Vaccine 77.8% Effective; 10 Things to Know About the Phase 3 Data
'Covaxin Has 77.8% Efficacy in Phase 3': What Do We Know So Far?